Where investors and patients join forces
- SYMBOL AVEX!
- NOTICE: AVEX Token is no longer supported and is replaced by AVEX!
- MULTI-PROTOCOL - AVEX! Token is a multi-protocol Sub-Token under the AEVOLVE ERC-1155 Smart Contract. It also contains NFT (ERC-721) digital assets to represent several components of AEVOLVE’s medical innovation financing model.
- ERC-20 (Ethereum Mainnet) – AVEX! on ETHERSCAN
- BEP-20 (Binance Smart Chain) on BSCSCAN
- OPENING MINT: 1.21 Million Tokens (Airdrops and starting Liquidity Pools)
- MAX 35,000,000 AVEX! Mint Potential for Exclusive Access Smart Contracts
- MAX 35,000,000 AVEX! Biospheres Treasury Match Mint based on Exclusive Access Smart Contracts Activity (Time LOCKED for Biospheres Medical Offerings Use)
- DECLINING INFLATION RATE: Token Growth from Declining Inflation Rate released monthly based on 1% of Total Minted Supply while interest rate also reduces by 1% monthly. Inflationary supply to be allocated for project reinvestment and staking rewards (Staking features coming soon).
Exclusive Access Smart Contracts incrementally mint a total based on 10% cumulative supply minted from an initial AVEX! 100K starting basis. The mint only is only activated once the previous 10% minted supply has been purchased.
The token value is driven by their utility in relation to the initial market offering available on the platform and the BIOSPHERES potential market offering. Aevolve’s market is designed to function primarily at a high utility value and minimize speculation over time. Aevolve is driven by actual medical solutions and products that address real-world demand and practical applications. AVEX! and SPHERE asset ownership are targeted towards patient-consumers.
THE NEW PATH TO PATIENT-DRIVEN TREATMENTS AND CURES
Aevolve is a protocol that supports medical innovations from R&D stages to full-scale commercialization, by connecting patients, investors, and scientific innovators.
FOR PATIENTS AND INNOVATORS
This innovation marketplace connects patients and the global community directly with scientific innovators and experts from all over the world to address various stages of the innovation life cycle.
INVESTOR ACCESS TO A BILLION-DOLLAR ECOSYSTEM
This new asset class provides exposure to opportunities in blockchain, free of the risks associated with previous token offerings. Coming soon to the the SIX Swiss Stock Exchange.
AVEX! Token & The Aevolve Protocol
Cutting-edge medical science meets blockchain-driven technology to create new opportunities to drive innovation.